Triptorelin
Pamorelin
Product Details
Brand NamePamorelin
FormatPowder for reconstitution and injection
Indication
- Palliative treatment of locally advanced, non-metastatic hormone dependent prostate cancer.
- Adjuvant treatment of metastatic hormone dependent prostate cancer.
- Adjuvant treatment to radio therapy in patients with high risk localized or locally advanced prostate cancer.
- Treatment of endometriosis
Formulation
Pamorelin 3.75mg Powder for Injection – Monthly Injections
Pamorelin 11.25mg Powder for Injection – Quarterly (every 3 months) Injections
Pamorelin 22.5mg Powder for Injection – Semester (every 6 months) Injections
Dosage and Administration
Please see Product Information Leaflet for complete information.
